GSK Investigational Site
Romford RM7 0AG
0 studies enrolling now · 3 studies all time
What they study most
Cerebrovascular Accident, Idiopathic Thrombocytopenic Purpura, Respiratory Syncytial Virus Infections
Studies at this site
- Efficacy Study of GSK's Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above — Completed
- Proof of Concept (POC) in Patients With Ischaemic Stroke — Stopped early
- Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body. — Completed